Literature DB >> 22544490

Supramolecular photochirogenesis with novel cyclic tetrasaccharide: enantiodifferentiating photoisomerization of (Z)-cyclooctene with cyclic nigerosylnigerose-based sensitizers.

Cheng Yang1, Wenting Liang, Masaki Nishijima, Gaku Fukuhara, Tadashi Mori, Hiroyuki Hiramatsu, Yasufumi Dan-oh, Kazuo Tsujimoto, Yoshihisa Inoue.   

Abstract

Isophthalic and terephthalic acid monoesters of cyclic nigerosyl-(1→6)-nigerose (CNN), a cyclic tetrasaccharide composed of four d-glucopyranosyl residues connected by alternating α-1,3- and α-1,6-linkages, were synthesized as novel chiral supramolecular sensitizers for enantiodifferentiating photoisomerization of (Z)-cyclooctene (1Z) to planar chiral (E)-isomer (1E). Despite the saucer-shaped shallow cavity of CNN that does not immediately guarantee strong ground-state interactions with 1Z, the sensitizer-appended CNNs afforded optically active 1E in such enantiomeric excesses that are much improved than those obtained with an α-cyclodextrin analog and comparable with those obtained with a β-cyclodextrin analog. Interestingly, the enantiomeric excess values obtained were a critical function of temperature and solvent to show an inversion of the product chirality by changing the environmental variants. Nevertheless, all of the differential activation parameters calculated from the temperature-dependent enantiomeric excesses gave an excellent compensatory enthalpy-entropy relationship, indicating an operation of a single enantiodifferentiating mechanism in the present chiral photosensitization with modified CNNs.
Copyright © 2012 Wiley Periodicals, Inc., A Wiley Company.

Entities:  

Year:  2012        PMID: 22544490     DOI: 10.1002/chir.22014

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  1 in total

Review 1.  Chiral Photocatalyst Structures in Asymmetric Photochemical Synthesis.

Authors:  Matthew J Genzink; Jesse B Kidd; Wesley B Swords; Tehshik P Yoon
Journal:  Chem Rev       Date:  2021-10-04       Impact factor: 60.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.